Message :
Required fields
ALPHARETTA, Ga., May 7, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2021 financial results.
"We executed well in the first quarter highlighted by building momentum across our franchises and controlling costs, while remaining focused on the health and safety of our employees and meeting the needs of patients impacted by the virus," stated Joe Woody, Avanos' chief executive officer. "Although at the start of the quarter we experienced a slowdown in our Pain Management franchise due to pandemic-related hospitalizations, as those began to decline, we saw an acceleration across our therapies."
Woody continued, "The financial guidance we are committing to illustrates the confidence in our ability to deliver top-line growth, margin improvement and generate free cash flow in 2021 and beyond."